Clinical trial Recruiting at 1 site Observational Ages 14 to 90

Impact of Metabolic Abnormalities and Lifestyle on Heart Failure

Official title: Estimation of Metabolic Abnormalities,Lifestyle Behaviors and Diet Pattern in Adults With Heart Failure

Run by Ruijin Hospital · NCT03951311 · Data updated 2026-11-12

This study is trying to see how things like diet, exercise, and metabolic health affect the long-term outcomes for people with heart failure.

More Heart Failure trials

Quick facts

Study typeObservational
Ages14 Years to 90 Years
SexAll
Enrollment1500 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedJune 1, 2016
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 8, 2021
Trial IDNCT03951311 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 14 years or older with heart failure and an ejection fraction of less than 50%.

Probably not a fit

Patients with heart failure due to non-cardiac diseases or those with a life expectancy of less than one year due to cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess how metabolic abnormalities, lifestyle behaviors, and dietary patterns affect the prognosis of heart failure in patients. It plans to enroll 1,500 participants aged 14 years and older who have heart failure with reduced or mid-range ejection fraction. Participants will be followed for five years, during which data on their metabolic health, lifestyle choices, and diet will be collected through standardized questionnaires. The study will also track major adverse cardiac events through medical records and discharge lists.

Why it matters

Potential benefit: If successful, this study could provide insights into how lifestyle and metabolic factors influence heart failure outcomes, potentially leading to improved management strategies.

How similar studies have gone: Other studies have shown that lifestyle and metabolic factors significantly impact heart failure outcomes, suggesting this approach is supported by existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. aged 14 years or older;
2. typical symptoms of heart failure according to the Framingham criteria;
3. left ventricular ejection fraction (LVEF) \<50%, demonstrated by echocardiography or cardiac magnetic resonance, which include either patients with mid-range EF (HFmEF) or with reduced EF (HFrEF) with relevant structural and functional cardiac changes and/or elevated N-terminal pro-brain B-type natriuretic peptide (pro-BNP) (e.g., ≥400 pg/mL).

Exclusion Criteria:

1. age \<14 years or ≥90 years;
2. pregnancy;
3. cancer with a life expectancy of less than one year;
4. participation in other trials;
5. endocarditis, pericardial diseases, or congenital heart diseases;
6. heart failure secondary to non-cardiac diseases (e.g., pulmonary heart disease, infection, infiltration, metabolic derangements, severe anemia, sepsis, and arteriovenous fistula);
7. lack of informed consent;
8. refusal of the drug treatment or intervention recommended by the guidelines.

Where it's running

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.